Kajsa Järvholm1,2, Torsten Olbers3, Markku Peltonen4, Claude Marcus5, Carl-Erik Flodmark6, Eva Gronowitz7, Jovanna Dahlgren7,8, Jan Karlsson9. 1. Childhood Obesity Unit, Skåne University Hospital, Malmö, Sweden. kajsa.jarvholm@gu.se. 2. Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. kajsa.jarvholm@gu.se. 3. Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. 4. National Institute for Health and Welfare, Helsinki, Finland. 5. Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. 6. Department of Clinical Sciences in Malmö, Lund University, Lund, Sweden. 7. Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 8. Region Västra Götaland, Regional Obesity Center, Sahlgrenska University Hospital, Gothenburg, Sweden. 9. University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Abstract
PURPOSE: Metabolic and bariatric surgery (MBS) is increasingly used in adolescents. The aim was to explore symptoms of depression and anxiety in young adults over 5 years' follow-up after undergoing MBS. METHODS: Beck Depression Inventory-2 and the Beck Anxiety Inventory were used to assess symptoms of depression and anxiety in 62 patients 1, 2, and 5 years after having Roux-en-Y gastric bypass at 13-18 years of age. Mental health, eating-related problems, and weight outcomes were tested for association with suicidal ideation at the 5-year follow-up. RESULTS: At the 5-year follow-up, the mean score for depression was 11.4 (± 12.4), indicating minimal symptoms of depression. The mean score for anxiety was 12.82 (± 11.50), indicating mild anxiety symptoms. Still, several participants reported moderate or severe symptoms of depression (26%) and anxiety (32%). Women reported more symptoms than men (P = 0.03 and 0.04). No significant changes were found in self-reported symptoms of depression and anxiety between the 1-year and the 5-year follow-up (P = 0.367 and 0.934). Suicidal ideation was reported by 16% at the 5-year follow-up. Participants reporting suicidal ideation had lost significantly less excess weight than participants without suicidal ideation (P = 0.009). CONCLUSION: Five years after adolescent MBS, a substantial minority still struggles with mental health issues, and women are more burdened than men. Our results indicate an association between less optimal weight loss and suicidal ideation 5 years after MBS. The findings emphasize the importance of offering long-term follow-up and mental health treatment several years after MBS. LEVEL OF EVIDENCE: Level III, cohort study. CLINICAL TRIAL REGISTRATION: The study is registered with ClinicalTrials.gov (NCT00289705). First posted February 10, 2006.
PURPOSE: Metabolic and bariatric surgery (MBS) is increasingly used in adolescents. The aim was to explore symptoms of depression and anxiety in young adults over 5 years' follow-up after undergoing MBS. METHODS:Beck Depression Inventory-2 and the Beck Anxiety Inventory were used to assess symptoms of depression and anxiety in 62 patients 1, 2, and 5 years after having Roux-en-Y gastric bypass at 13-18 years of age. Mental health, eating-related problems, and weight outcomes were tested for association with suicidal ideation at the 5-year follow-up. RESULTS: At the 5-year follow-up, the mean score for depression was 11.4 (± 12.4), indicating minimal symptoms of depression. The mean score for anxiety was 12.82 (± 11.50), indicating mild anxiety symptoms. Still, several participants reported moderate or severe symptoms of depression (26%) and anxiety (32%). Women reported more symptoms than men (P = 0.03 and 0.04). No significant changes were found in self-reported symptoms of depression and anxiety between the 1-year and the 5-year follow-up (P = 0.367 and 0.934). Suicidal ideation was reported by 16% at the 5-year follow-up. Participants reporting suicidal ideation had lost significantly less excess weight than participants without suicidal ideation (P = 0.009). CONCLUSION: Five years after adolescent MBS, a substantial minority still struggles with mental health issues, and women are more burdened than men. Our results indicate an association between less optimal weight loss and suicidal ideation 5 years after MBS. The findings emphasize the importance of offering long-term follow-up and mental health treatment several years after MBS. LEVEL OF EVIDENCE: Level III, cohort study. CLINICAL TRIAL REGISTRATION: The study is registered with ClinicalTrials.gov (NCT00289705). First posted February 10, 2006.
Authors: Leonore de Wit; Floriana Luppino; Annemieke van Straten; Brenda Penninx; Frans Zitman; Pim Cuijpers Journal: Psychiatry Res Date: 2010-05-13 Impact factor: 3.222
Authors: Stephan Herpertz; Astrid Müller; Ramona Burgmer; Ross D Crosby; Martina de Zwaan; Tanja Legenbauer Journal: Surg Obes Relat Dis Date: 2015-04-22 Impact factor: 4.734
Authors: Kajsa Järvholm; Gustaf Bruze; Markku Peltonen; Claude Marcus; Carl-Erik Flodmark; Pia Henfridsson; Andrew J Beamish; Eva Gronowitz; Jovanna Dahlgren; Jan Karlsson; Torsten Olbers Journal: Lancet Child Adolesc Health Date: 2020-01-21
Authors: Thomas H Inge; Todd M Jenkins; Stavra A Xanthakos; John B Dixon; Stephen R Daniels; Meg H Zeller; Michael A Helmrath Journal: Lancet Diabetes Endocrinol Date: 2017-01-06 Impact factor: 32.069
Authors: James E Mitchell; Wendy C King; Jia-Yuh Chen; Michael J Devlin; David Flum; Luis Garcia; William Inabet; John R Pender; Melissa A Kalarchian; Saurabh Khandelwal; Marsha D Marcus; Beth Schrope; Gladys Strain; Bruce Wolfe; Susan Yanovski Journal: Obesity (Silver Spring) Date: 2014-03-25 Impact factor: 5.002
Authors: Catherine Verity Homer; Angela Mary Tod; Andrew R Thompson; Peter Allmark; Elizabeth Goyder Journal: BMJ Open Date: 2016-02-08 Impact factor: 2.692
Authors: Torsten Olbers; Andrew J Beamish; Eva Gronowitz; Carl-Erik Flodmark; Jovanna Dahlgren; Gustaf Bruze; Kerstin Ekbom; Peter Friberg; Gunnar Göthberg; Kajsa Järvholm; Jan Karlsson; Staffan Mårild; Martin Neovius; Markku Peltonen; Claude Marcus Journal: Lancet Diabetes Endocrinol Date: 2017-01-06 Impact factor: 32.069